Alpha Cognition Inc
ACOG
Rang in aandelen
#20416
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Aandeelprijs
$8.13
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$126.27M
Verandering (1 dag)
-3.79%
Verandering (1 jaar)
61.63%
Land
US
Handel Alpha Cognition Inc (ACOG)
Categorie
Healthcare
EPS voor Alpha Cognition Inc (ACOG)
EPS per June 2026 TTM: $-0.40
Volgens de laatste financiële rapporten en de aandelenkoers van Alpha Cognition Inc is de huidige EPS van het bedrijf (TTM) $-0.40. Eind 2022 had het bedrijf een EPS van $-0.18, een daling ten opzichte van de EPS van 2021 die $-0.37 bedroeg.
EPS-geschiedenis van Alpha Cognition Inc van 2018 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-0.40 | 166.67% |
| 2023 | $-0.15 | -16.67% |
| 2022 | $-0.18 | -51.35% |
| 2021 | $-0.37 | -61.46% |
| 2020 | $-0.96 | 357.14% |
| 2019 | $-0.21 | 672.06% |
| 2018 | $-0.03 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $17.32 | -4,430.00% |
US
|
|
| $-7.98 | 1,895.00% |
US
|
|
| $-5.29 | 1,222.50% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -7,035.00% |
NL
|
